Subspecialties: Page 122

Elastography, vascularity measures improve TI-RADS performance

By Amerigo Allegretto

Measures from thyroid nodule vascularity and shear-wave elastography show promise for improving the detection of thyroid cancer, according to findings presented at the American Roentgen Ray Society annual meeting in Honolulu.

April 18, 2023

PET/CT key to imaging patients with prostate cancer

By Will Morton

PET/CT imaging with novel radiotracers has emerged over the past several years as a first-line approach for diagnosing and monitoring treatments in patients with prostate cancer, according to an April 16 presentation at ARRS 2023 in Honolulu, HI.

April 18, 2023

FDA clears RapidAI's CT imaging stroke assessment software

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has cleared artificial intelligence (AI) software developer RapidAI's CT imaging stroke assessment software.

April 17, 2023

Elastography quality important in liver disease prediction

By Amerigo Allegretto

The quality of the shear-wave elastography exam matters when creating a prediction model for nonalcoholic fatty liver disease, suggest findings presented April 17 at the American Roentgen Ray Society annual meeting.

April 17, 2023

3D printing, 4D flow MRI can aid atrial fibrillation treatment

By Erik L. Ridley

4D flow MRI of 3D-printed models has revealed an important clinical goal for the treatment of patients with atrial fibrillation, according to research presented at the annual meeting of the American Roentgen Ray Society in Honolulu, HI.

April 17, 2023

3D slice-to-volume MRI can 'see' fetal optic pathway

By Amerigo Allegretto

3D slice-to-volume MRI can help accurately describe and measure the fetal optic pathway, according to findings presented April 16 at the American Roentgen Ray Society (ARRS) annual meeting in Hawaii.

April 17, 2023

Racial disparities persist in genitourinary clinical trials

By Will Morton

Racial disparities persist in genitourinary clinical trials of new biologic drugs and PET imaging radiotracers, according to a study published April 13 in Current Problems in Cancer.

April 16, 2023

Advantis gets FDA clearance for MRI analysis software

By AuntMinnie.com staff writers

Imaging software developer Advantis Medical Imaging has garnered U.S. Food and Drug Administration (FDA) clearance for its Advantis Platform brain and prostate MRI analysis software.

April 13, 2023

Ultrasound noninferior to scintigraphy in surgical thyroid imaging

By Amerigo Allegretto

Ultrasound may be a viable alternative to scintigraphy for pre-surgical imaging of patients with primary hyperparathyroidism, even without the addition of contrast media, suggest findings published April 13 in JAMA Otolaryngology.

April 13, 2023

CT body composition assessment helps determine lung cancer prognosis

By Kate Madden Yee

Assessing lung cancer sufferers' body composition with CT imaging can help clinicians determine whether patients have developed cancer-associated cachexia (CAC), and thus assess prognosis, according to a study published April 12 in Nature Medicine.

April 13, 2023

Imaging protocol described for thyroid treatment

By Amerigo Allegretto

Ultrasound or sestamibi scans followed by CT may be the way to go for localizing target areas in patients undergoing reoperative parathyroidectomy, findings published April 12 in the American Journal of Surgery.

April 13, 2023

PET tracer for prostate cancer performs well in phase III trial

By Will Morton

PET/CT imaging with F-18 PSMA-1007 detects significantly more prostate cancer than imaging using the standard F-18 fluorocholine radiotracer, according to clinical results published in the April issue of the Journal of Nuclear Medicine.

April 13, 2023

Previous Page

Page 122 of 1582

Next Page